LY2624803
Modify Date: 2025-09-10 23:51:31
LY2624803 structure
|
Common Name | LY2624803 | ||
|---|---|---|---|---|
| CAS Number | 879409-35-5 | Molecular Weight | 379.452 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 554.3±60.0 °C at 760 mmHg | |
| Molecular Formula | C22H25N3O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 289.0±32.9 °C | |
Use of LY2624803LY2624803 is a novel potent histamine H1 and 5HT-2A receptor modulator in the pipeline for treating insomnia. Sleep Disorder Phase 2 Discontinued |
| Name | Ly-2624803 |
|---|---|
| Synonym | More Synonyms |
| Description | LY2624803 is a novel potent histamine H1 and 5HT-2A receptor modulator in the pipeline for treating insomnia. Sleep Disorder Phase 2 Discontinued |
|---|---|
| References | References 1. Zisapel N. Expert Opin Investig Drugs. 2015 Mar;24(3):401-11. View Related Products by Target Histamine Receptor Sleep Disorder |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 554.3±60.0 °C at 760 mmHg |
| Molecular Formula | C22H25N3O3 |
| Molecular Weight | 379.452 |
| Flash Point | 289.0±32.9 °C |
| Exact Mass | 379.189606 |
| LogP | 2.64 |
| Vapour Pressure | 0.0±1.6 mmHg at 25°C |
| Index of Refraction | 1.630 |
| InChIKey | UEFWDVMEDFCHGW-UHFFFAOYSA-N |
| SMILES | CC(C)(CN1CCN(C2=Nc3ccccc3Oc3ccccc32)CC1)C(=O)O |
| Ly-2624803 |
| 1-Piperazinepropanoic acid, 4-dibenz[b,f][1,4]oxazepin-11-yl-α,α-dimethyl- |
| 3-[4-(Dibenzo[b,f][1,4]oxazepin-11-yl)-1-piperazinyl]-2,2-dimethylpropanoic acid |